2H-4,8-Methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-
CAS: 1454846-35-5
Ref. IN-DA001D3G
1g | 328.00 € | ||
5g | To inquire | ||
25mg | 38.00 € | ||
100mg | 60.00 € | ||
250mg | 117.00 € |
Estimated delivery in United States, on Thursday 9 Jan 2025
Product Information
Name:
2H-4,8-Methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-
Synonyms:
- lorlatinib
- Lorlatinib
- Loratinib
- Lorbrena
- (10r)-7-Amino-12-Fluoro-2,10,16-Trimethyl-15-Oxo-10,15,16,17-Tetrahydro-2h-8,4-(Metheno)pyrazolo[4,3-H][2,5,11]benzoxadiazacyclotetradecine-3-Carbonitrile
- lorlantinib
- lorlatinibum
- 4cli
- 4clj
- Rostafuroxin
- See more synonyms
- (10R)-7-Amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile
- Lorviqua
- Pf0643922
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Indagoo
Long term storage:
Notes:
Chemical properties
Molecular weight:
406.4130
Formula:
C21H19FN6O2
Purity:
98%
Color/Form:
Solid
InChI:
InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1
InChI key:
IIXWYSCJSQVBQM-LLVKDONJSA-N
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: IN-DA001D3G 2H-4,8-Methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.